Samuel Z - Search Results

1

Can a gastrointestinal pathologist identify microsatellite instability in colorectal cancer with reproducibility and a high degree of specificity?

Brazowski E, Rozen P, Pel S, Samuel Z, Solar I, Rosner G. Brazowski E, et al. Among authors: samuel z. Fam Cancer. 2012 Jun;11(2):249-57. doi: 10.1007/s10689-012-9508-8. Fam Cancer. 2012. PMID: 22246243

2

An audit of familial juvenile polyposis at the Tel Aviv Medical Center: demographic, genetic and clinical features.

Rozen P, Samuel Z, Brazowski E, Jakubowicz M, Rattan J, Halpern Z. Rozen P, et al. Among authors: samuel z. Fam Cancer. 2003;2(1):1-7. doi: 10.1023/a:1023226909534. Fam Cancer. 2003. PMID: 14574161

3

Clinical and screening implications of the I1307K adenomatous polyposis coli gene variant in Israeli Ashkenazi Jews with familial colorectal neoplasia. Evidence for a founder effect.

Rozen P, Naiman T, Strul H, Taussky P, Karminsky N, Shomrat R, Samuel Z, Yaron Y, Orr-Urtreger A. Rozen P, et al. Among authors: samuel z. Cancer. 2002 May 15;94(10):2561-8. doi: 10.1002/cncr.10529. Cancer. 2002. PMID: 12173321 Free article.

4

Comparative screening with a sensitive guaiac and specific immunochemical occult blood test in an endoscopic study.

Rozen P, Knaani J, Samuel Z. Rozen P, et al. Among authors: samuel z. Cancer. 2000 Jul 1;89(1):46-52. Cancer. 2000. PMID: 10896999 Clinical Trial.

5

A prospective study of the clinical, genetic, screening, and pathologic features of a family with hereditary mixed polyposis syndrome.

Rozen P, Samuel Z, Brazowski E. Rozen P, et al. Among authors: samuel z. Am J Gastroenterol. 2003 Oct;98(10):2317-20. doi: 10.1111/j.1572-0241.2003.07714.x. Am J Gastroenterol. 2003. PMID: 14572586

6

Familial adenomatous polyposis at the Tel Aviv Medical Center: demographic and clinical features.

Rozen P, Samuel Z, Rabau M, Goldman G, Shomrat R, Legum C, Orr-Urtreger A. Rozen P, et al. Among authors: samuel z. Fam Cancer. 2001;1(2):75-82. doi: 10.1023/a:1013888226756. Fam Cancer. 2001. PMID: 14574001

7

Eliminating the need for dietary restrictions when using a sensitive guaiac fecal occult blood test.

Rozen P, Knaani J, Samuel Z. Rozen P, et al. Among authors: samuel z. Dig Dis Sci. 1999 Apr;44(4):756-60. doi: 10.1023/a:1026618010312. Dig Dis Sci. 1999. PMID: 10219834

8

Performance characteristics and comparison of two immunochemical and two guaiac fecal occult blood screening tests for colorectal neoplasia.

Rozen P, Knaani J, Samuel Z. Rozen P, et al. Among authors: samuel z. Dig Dis Sci. 1997 Oct;42(10):2064-71. doi: 10.1023/a:1018866400973. Dig Dis Sci. 1997. PMID: 9365136

9

Notable intrafamilial phenotypic variability in a kindred with familial adenomatous polyposis and an APC mutation in exon 9.

Rozen P, Samuel Z, Shomrat R, Legum C. Rozen P, et al. Among authors: samuel z. Gut. 1999 Dec;45(6):829-33. doi: 10.1136/gut.45.6.829. Gut. 1999. PMID: 10562580 Free PMC article.

10

Can patients at high risk for significant colorectal neoplasms and having normal quantitative faecal occult blood test postpone elective colonoscopy?

Hazazi R, Rozen P, Leshno M, Levi Z, Samuel Z, Waked A, Vilkin A, Maoz E, Birkenfeld S, Niv Y. Hazazi R, et al. Among authors: samuel z. Aliment Pharmacol Ther. 2010 Feb 15;31(4):523-33. doi: 10.1111/j.1365-2036.2009.04202.x. Epub 2009 Nov 19. Aliment Pharmacol Ther. 2010. PMID: 19925498

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters